OCGN Earnings & Financial Statements
Ocugen, Inc.
$0.84
-$0.04(-4.99%)
28
Overall
40
Value
10
Tech
36
Quality
Market Cap
$285.26M
Volume
9.51M
52W Range
$0.90 - $2.73
Target Price
$10.61
OCGN earnings and financial statements: Ocugen, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
OCGN Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $4.41M | $4.05M | $6.04M | $2.49M | - |
| Operating income | -$62.92M | -$54.76M | -$65.53M | -$89.07M | -$58.03M |
| EBITDA | -$58.95M | -$51.38M | -$62.37M | -$88.59M | -$57.80M |
| Net income | -$67.85M | -$54.05M | -$63.08M | -$86.80M | -$58.37M |
| EPS (diluted) | - | $-0.20 | $-0.26 | $-0.38 | $-0.30 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $43.52M | $82.44M | $64.55M | $108.63M | $105.76M |
| Total liabilities | $55.68M | $52.81M | $23.98M | $34.65M | $9.94M |
| Shareholders’ equity | -$12.17M | $29.63M | $40.56M | $73.98M | $95.82M |
| Cash and equivalents | $18.57M | $58.51M | $39.46M | $77.56M | $94.96M |
| Long-term debt | $31.04M | $30.66M | $6.37M | $5.88M | $2.94M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$56.96M | -$42.14M | -$62.05M | -$60.08M | -$47.94M |
| Capital expenditure | -$185.0K | -$3.38M | -$10.48M | -$4.46M | -$939.0K |
| Free cash flow | -$57.15M | -$45.53M | -$72.53M | -$64.54M | -$48.88M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OCGN | $0.84 | -5.0% | 9.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |